HENIK
LIVE

Serial Number

88425574

Owner

Aphria Inc.

Attorney

Peter S. Sloane

Filing Date

May 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HENIK Trademark

Serial Number: 88425574 • Registration: 6674770

HENIK is a trademark filed by Aphria Inc. on May 10, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products), Class 34 (Smokers Articles). The application is currently registered and active.

Owner Contact Info

Aphria Inc. (125 trademarks)

265 Talbot Street West
Leamington, Ontario N8H4H3 , CA

Entity Type: 99

Trademark Details

Filing Date

May 10, 2019

Registration Date

March 22, 2022

Published for Opposition

January 4, 2022

Goods & Services

Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter; fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing solely derived from hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing solely derived from cannabis with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of flavorings in liquid form, other than essential oils for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives being flavorings in liquid form, other than essential oils for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; smokers' articles, namely, pouches for use with hemp, lighters for smokers; all of the foregoing solely derived from hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD or exclusively for use with goods solely derived from hemp having a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing solely derived from hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 27, 2025 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 30, 2021 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 23, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 17, 2021 ZZZX
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2021 COAR
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 21, 2021 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Sep 8, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 3, 2021 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Aug 30, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Aug 27, 2021 ERRR
EXPARTE APPEAL TERMINATED
Aug 22, 2021 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 20, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 20, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 20, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 20, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 20, 2021 CNEA
ASSIGNED TO EXAMINER
Jun 15, 2021 DOCK
ASSIGNED TO EXAMINER
Apr 16, 2021 DOCK
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 1, 2021 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jan 14, 2021 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jan 14, 2021 GECD
ACTION CONTINUING FINAL - COMPLETED
Jan 14, 2021 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 23, 2020 ERFR
EX PARTE APPEAL-INSTITUTED
Nov 23, 2020 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 23, 2020 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 23, 2020 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
May 21, 2020 GNFN
FINAL REFUSAL E-MAILED
May 21, 2020 GNFR
FINAL REFUSAL WRITTEN
May 21, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2020 CRFA
ASSIGNED TO LIE
Apr 22, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2019 DOCK
ASSIGNED TO EXAMINER
May 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
NEW APPLICATION ENTERED
May 14, 2019 NWAP